Menactra

Generic name: Meningococcal Conjugate Vaccine
Drug class: Bacterial vaccines

Usage of Menactra

Menactra is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis. Meningococcal vaccine will not treat an active meningococcal infection that has already developed in the body.

Menactra is for use in children and adults between the ages of 9 months and 55 years old.

Meningococcal disease is a bacterial infection that can infect the spinal cord and brain and cause meningitis, which can be fatal or lead to permanent and disabling medical problems.

Meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.

Menactra is for use in children and adults between the ages of 9 months and 55 years old.

Meningococcal disease is more likely to occur in babies younger than 1 year, in young people ages 16 to 23 years, in anyone with a weak immune system, those without a functioning spleen, and in anyone exposed to an outbreak of the disease.

Menactra works by exposing you to a small dose of the bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. Menactra contains four of the most common types of meningococcal bacteria (serogroups A, C, Y, and W-135).

Like any vaccine, Menactra may not provide protection from disease in every person.

Menactra side effects

Get emergency medical help if you have signs of an allergic reaction to Menactra: hives; dizziness, weakness; fast heartbeats; difficult breathing; swelling of your face, lips, tongue, or throat.

Keep track of all side effects you have. If you need a booster dose, you will need to tell the vaccination provider if the previous shot caused any side effects.

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.

Becoming infected with meningococcal disease and developing meningitis is much more dangerous to your health than receiving Menactra. Any vaccine may cause side effects but the risk of serious side effects is low.

You may feel faint after receiving Menactra. Some people have had seizure like reactions after receiving this vaccine. Your doctor may want you to remain under observation during the first 15 minutes after the injection.

Call your doctor at once if you have:

severe weakness or unusual feeling in your arms and legs (may occur 2 to 4 weeks after you receive the vaccine);

high fever; or

unusual behavior.

Common Menactra side effects may include:

nausea, vomiting, diarrhea;

changes in appetite;

redness, pain, swelling, or a hard lump where the shot was given;

joint or muscle pain;

headache, drowsiness, tiredness

low fever, not feeling well; or

(in babies) fussiness, irritability.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1 800 822 7967.

Before taking Menactra

You may not be able to receive Menactra if you've ever had an allergic reaction to a meningococcal, diphtheria, or tetanus vaccine.

Menactra may need to be postponed or not given at all if you have:

a severe illness with a fever or any type of infection;

a weak immune system caused by disease or by using certain medicine (Menactra may not be as effective if you are immunosuppressed);

a history of Guillain-Barré syndrome; or

a history of premature birth.

You can still receive a vaccine if you've a minor cold.

Your doctor should determine whether you need Menactra during pregnancy or while breastfeeding.

Relate drugs

How to use Menactra

Menactra is given as a 0.5ml dose by intramuscular injection. Do not administer Menactra intravenously or suBCutaneously.

Primary Vaccination:

In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart.

In people from 2 years old, up to and including 55 years of age, Menactra is given as a single dose.

Booster Vaccination:

A single booster dose may be given to people from 15 years old, up to and including 55 years of age who are at a continued risk of meningococcal disease, if at least 4 years have elapsed since since receiving a dose of a Meningococcal conjugate vaccine.

Warnings

You should not receive Menactra if you have ever had an allergic reaction to a meningococcal or diphtheria vaccine.

You should not receive a booster vaccine if you had a life threatening allergic reaction after the first shot.

What other drugs will affect Menactra

Tell your doctor about all other vaccines you recently received, especially:

a diphtheria, tetanus, and pertussis vaccine (such as Daptacel); or

a pneumonia vaccine (such as Prevnar).

This list is not complete. Other drugs may interact with meningococcal conjugate vaccine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.